Literature DB >> 3971537

Influence of coronary collateral blood flow on the development of exertional ischemia and Q wave infarction in patients with severe single-vessel disease.

S B Freedman, R F Dunn, L Bernstein, J Morris, D T Kelly.   

Abstract

The functional significance of coronary collateral flow from a nonobstructed supply artery was studied in 121 patients with severe (greater than or equal to 80%) single-vessel disease, 64 with and 57 without Q wave infarction. All patients underwent exercise thallium imaging and coronary angiography. On angiography, collateral flow was present in 85% of 74 occluded arteries compared with only 17% of 47 arteries with subtotal obstruction (p less than .001). Collateral flow was not seen in arteries with lesions of less than 90% obstruction. Collateral flow was present in 100% of 29 occluded arteries in patients without Q wave infarction compared with only 76% of 45 occluded arteries with Q wave infarction (p less than .005). Clinical variables did not correlate with collateral flow. Collateral flow did not prevent ischemia on exercise thallium imaging in patients without Q wave infarction: 30 of 33 (91%) with collateral flow had reversible thallium defects compared with 24 of 24 (100%) without collateral flow (p = NS). In patients with Q wave infarction, partially reversible exercise thallium defects (peri-infarctional ischemia) were more common with flow to the area from either subtotal obstruction (73%) or collateral flow (45%) than with no flow from total occlusion (27%; p = .05). In patients with severe single-vessel disease the presence of collateral flow is principally determined by coronary occlusion. Collateral flow may protect from Q wave infarction but does not prevent exercise ischemia on thallium imaging.

Entities:  

Mesh:

Year:  1985        PMID: 3971537     DOI: 10.1161/01.cir.71.4.681

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Physiologic capacity of well-developed collaterals in patients with isolated left anterior descending artery disease.

Authors:  K Sakata; H Yoshida; N Ono; S Ohtani; N Mori; S Yokoyama; T Hoshino; T Kaburagi; C Kurata
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

2.  Protective effect of collateral vessels during coronary angioplasty.

Authors:  M S Norell; J P Lyons; J E Gardener; C A Layton; R Balcon
Journal:  Br Heart J       Date:  1989-10

3.  Noninvasive detection of collateral flow to the infarct-related coronary artery in patients after myocardial infarction by Tl-201 tomographic imaging.

Authors:  Pierre Chouraqui; Arik Asman; Victor Guetta; Fathy Daka; Jack Baron; Eli Rozen; Matan Sternberg; Michael Shechter
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

4.  Importance of angina for development of collateral circulation.

Authors:  M Fujita; S Sasayama; A Ohno; H Nakajima; H Asanoi
Journal:  Br Heart J       Date:  1987-02

Review 5.  Imaging myocardial angiogenesis.

Authors:  Joanna J Wykrzykowska; Timothy D Henry; John R Lesser; Robert S Schwartz
Journal:  Nat Rev Cardiol       Date:  2009-09-08       Impact factor: 32.419

6.  The delay of contrast arrival in magnetic resonance first-pass perfusion imaging: a novel non-invasive parameter detecting collateral-dependent myocardium.

Authors:  O M Muehling; A Huber; C Cyran; S O Schoenberg; M Reiser; G Steinbeck; M Nabauer; M Jerosch-Herold
Journal:  Heart       Date:  2007-03-07       Impact factor: 5.994

Review 7.  Novel revascularization therapies--TMLR and growth factor-induced angiogenesis monitored with cardiac MRI.

Authors:  N M Wilke; A Zenovich; O Muehling; M Jerosch-Herold
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.533

8.  Observed influence of nitroglycerine on myocardial perfusion scintigraphy in patients with multiple vessel coronary artery disease and well-developed collaterals.

Authors:  Nigora Rasulova; Lyudmila Nazirova; Khasan Akhmedov; Dilyafruz Akhmedova; Farrukh Djalalov; Amet Seydaliev; Farkhod Iskandarov; T Y Kok
Journal:  World J Nucl Med       Date:  2012-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.